Original Research
Published on 07 Nov 2025
Assessment of the risk of discontinuation of tenofovir disoproxil fumarate after delivery and the benefit of continued treatment in patients with immune tolerance
in Infectious Diseases: Pathogenesis and Therapy
- 104 views